Literature DB >> 17704449

A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center.

Fiona Brown1, Wen Jiun Liu, Despina Kotsanas, Tony M Korman, Robert C Atkins.   

Abstract

BACKGROUND: Peritonitis remains one of the major complications of peritoneal dialysis (PD) and results in reduced technique survival and increased patient morbidity and mortality.
METHODS: We prospectively recorded comprehensive data on all episodes of PD peritonitis over a 25-year period, including organisms isolated and antibiotic sensitivities. Data on 1588 PD patient-years with 2073 episodes of peritonitis were analyzed; 2089 organisms were isolated in 608 patients. Peritoneal dialysis technique and patient survival were also recorded.
RESULTS: There was a significant decline over the years in the incidence of peritonitis, from 6.5 to 0.35 episodes/patient-year, with the decline in the post twin-bag era from 2.3 to 0.47 (p < 0.001) due primarily to a decrease in gram-positive organisms. The most common isolates (68.9%) were gram-positive organisms; gram-negative organisms comprised 26.8% and fungi 4.1%. Coagulase-negative staphylococci were the most common pathogen isolated (35.3%). Culture-negative peritonitis was seen in 13.4% of episodes.
CONCLUSION: This is the largest series of PD peritonitis reported, demonstrating a dramatic reduction over a 25-year period and also detailing the changing trends of organisms isolated in association with improved technique and patient survival. Although rates have improved, peritonitis remains a major complication and further research needs to be done to improve both PD technique and patient survival.

Entities:  

Mesh:

Year:  2007        PMID: 17704449

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  12 in total

1.  Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).

Authors:  Julie M Varghese; Jason A Roberts; Steven C Wallis; Robert J Boots; Helen Healy; Robert G Fassett; Jeffrey Lipman; Dwarakanathan Ranganathan
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

2.  Lower education level is a major risk factor for peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up.

Authors:  Yahn-Bor Chern; Pei-Shan Ho; Li-Chueh Kuo; Jin-Bor Chen
Journal:  Perit Dial Int       Date:  2013-04-01       Impact factor: 1.756

3.  Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada.

Authors:  Jeffrey Perl; Ron Wald; Joanne M Bargman; Yingbo Na; S Vanita Jassal; Arsh K Jain; Louise Moist; Sharon J Nessim
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

4.  Population Pharmacokinetics of Intraperitoneal Gentamicin and the Impact of Varying Dwell Times on Pharmacodynamic Target Attainment in Patients with Acute Peritonitis Undergoing Peritoneal Dialysis.

Authors:  Andras Farkas; Katerina Oikonomou; Mohammad Ghanbar; Phillip Villasurda; Julie Varghese; Jeffrey Lipman; Joseph Sassine; Dwarakanathan Ranganathan; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2021-12-13       Impact factor: 5.938

5.  Effect of gastric acid suppressants and prokinetics on peritoneal dialysis-related peritonitis.

Authors:  Ji Eun Kwon; Seong-Joon Koh; Jaeyoung Chun; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

6.  Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).

Authors:  Dwarakanathan Ranganathan; Saiyuri Naicker; Steven C Wallis; Jeffrey Lipman; Sharad K Ratanjee; Jason A Roberts
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

Review 7.  Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina El Dib
Journal:  BMC Infect Dis       Date:  2014-08-18       Impact factor: 3.090

8.  Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis.

Authors:  Amanda L McGuire; Sophia C Bennett; Sally M Lansley; Natalia D Popowicz; Julius F Varano della Vergiliana; Daniel Wong; Y C Gary Lee; Aron Chakera
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

9.  Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study.

Authors:  Dwarakanathan Ranganathan; Julie M Varghese; Robert G Fassett; Jeffrey Lipman; Vincent D'Intini; Helen Healy; Jason A Roberts
Journal:  BMC Nephrol       Date:  2009-12-16       Impact factor: 2.388

10.  Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin.

Authors:  Julia V Marley; Sarah Moore; Cherelle Fitzclarence; Kevin Warr; David Atkinson
Journal:  Aust J Rural Health       Date:  2014-06       Impact factor: 1.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.